66 top medical experts on Gangliosidoses across 8 countries and 2 U.S. states, including 7 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Gangliosidoses: A group of autosomal recessive lysosomal storage disorders marked by the accumulation of gangliosides. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the lysosomes. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Sphingolipidoses (136) and Narrower Categories: GM1 Gangliosidosis (648), GM2 Gangliosidoses (357).
  4. Clinical Trials ClinicalTrials.gov : at least 26 including 2 Active, 6 Completed, 13 Recruiting


  

        

                    


    Computing Expert Listing ...

);